https://breye.com/novo-holdings-and-sound-bioventures-launch-breye-therapeutics-to-develop-novel-oral-therapies-for-ophthalmologic-diseases/2023-04-18T09:43:15+01:00https://breye.com/breye-therapeutics-strengthens-management-team-and-board/2023-04-20T08:33:36+01:00https://breye.com/golgi-neurosciences-and-breye-therapeutics-announce-successful-closing-of-p2x7-receptor-antagonist-program-transfer/2023-07-25T08:00:02+01:00https://breye.com/breye-therapeutics-commences-oral-dosing-of-danegaptide-in-patients-with-diabetic-retinopathy/2024-01-25T08:31:29+00:00https://breye.com/breye-therapeutics-announces-successful-completion-of-its-phase-1b-trial-with-danegaptide-in-patients-with-diabetic-retinopathy/2025-06-24T08:30:45+01:00https://breye.com/25th-euretina-congress-2025/2025-09-29T10:07:54+01:00https://breye.com/jpm-annual-healthcare-conference-2026/2025-09-29T10:05:11+01:00https://breye.com/bioequity-europe-2025/2025-09-29T10:07:02+01:00https://breye.com/bioeurope-spring-2025/2025-09-29T10:09:57+01:00https://breye.com/jpm-annual-healthcare-conference-2025/2025-09-29T10:10:51+01:00https://breye.com/novo-holdings-seed-summit-2025/2025-09-29T15:41:06+01:00https://breye.com/optimum-17th-annual-healthcare-investor-conference-2025/2025-09-30T09:39:34+01:00https://breye.com/bio-europe-2025/2025-09-29T15:38:07+01:00https://breye.com/lsx-investival-showcase-europe-2025/2025-10-06T16:44:21+01:00https://breye.com/london-life-sciences-week/2025-10-06T13:24:18+01:00https://breye.com/jpm-annual-healthcare-conference-2024/2025-09-29T10:50:06+01:00https://breye.com/arvo-annual-meeting-2024/2025-09-29T10:50:58+01:00https://breye.com/2024-gordon-research-conference/2025-09-29T10:51:45+01:00https://breye.com/bio-2024/2025-09-29T10:53:03+01:00https://breye.com/novo-holdings-seed-summit-2024/2025-09-29T10:53:38+01:00https://breye.com/epm-2024-2nd-european-purine-meeting/2025-09-29T10:54:31+01:00https://breye.com/24th-euretina-congress/2025-09-29T10:55:14+01:00https://breye.com/optimum-strategic-communications-16th-annual-healthcare-investor-conference/2025-09-29T10:56:10+01:00https://breye.com/virtual-angiogenesis-exudation-and-degeneration-meeting-2026/2026-02-06T14:06:15+00:00https://breye.com/bio-europe-spring-2026/2026-02-06T14:05:52+00:00https://breye.com/strong-clinical-data-for-breye-therapeutics-lead-oral-asset-danegaptide-presented-at-angiogenesis-exudation-and-degeneration-2026-symposium/2026-02-09T08:31:11+00:00